Dyne Therapeutics Unveils Promising Preclinical FSHD Data from FORCEā¢ Platform
Jun 14, 2024
Preclinical Invest Advisor
Athira Pharma Showcases Preclinical Data of Fosgonimeton: A Potential Defense Against Alzheimer's Disease Pathology
Nov 16, 2023